Liraglutide does not provide sustainable results for weight improvement in adolescents with obesity

Affiliations

¹ General Paediatrics, Royal Hospital for Children, Glasgow, UK c.brady1@nhs.net.
² Endocrinology, Royal Hospital for Sick Children, Glasgow, Glasgow, UK.

Comment

Clare Brady et al. Arch Dis Child Educ Pract Ed. 2022 Jun.

. 2022 Jun;107(3):232.

doi: 10.1136/archdischild-2020-319807. Epub 2020 Sep 28.

¹ General Paediatrics, Royal Hospital for Children, Glasgow, UK c.brady1@nhs.net.
² Endocrinology, Royal Hospital for Sick Children, Glasgow, Glasgow, UK.

No abstract available

Keywords: adolescent health; growth; obesity; therapeutics.

Conflict of interest statement

Competing interests: None declared.

A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.
Kelly AS, Auerbach P, Barrientos-Perez M, Gies I, Hale PM, Marcus C, Mastrandrea LD, Prabhu N, Arslanian S; NN8022-4180 Trial Investigators. Kelly AS, et al. N Engl J Med. 2020 May 28;382(22):2117-2128. doi: 10.1056/NEJMoa1916038. Epub 2020 Mar 31. N Engl J Med. 2020. PMID: 32233338 Clinical Trial.